XML 44 R34.htm IDEA: XBRL DOCUMENT v3.25.3
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Details Narrative)
3 Months Ended 9 Months Ended
Sep. 18, 2025
USD ($)
$ / shares
shares
Apr. 09, 2025
USD ($)
Feb. 03, 2025
USD ($)
Jan. 30, 2025
USD ($)
Segment
$ / shares
shares
Sep. 30, 2025
USD ($)
shares
Mar. 31, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
Mar. 31, 2024
shares
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
May 21, 2025
shares
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercise of the warrants       $ 4,244,467              
Engagement agreement description       (i) a cash fee equal to 7.0% of the aggregate gross proceeds received in the Offering, (ii) a management fee equal to 1.0% of the aggregate gross proceeds received in the Offering, (iii) a non-accountable expense allowance of $25,000, (iv) reimbursement of up to $100,000 for legal fees and expenses and other out of pocket expenses and (v) up to $15,950 for the clearing expenses.              
Non-accountable expense allowance       $ 25,000              
Legal fees $ 334,659     100,000              
clearing expenses       $ 15,950              
Ffair value of Warrant $ 2,150,111               $ (858) $ (20,722)  
Gross proceeds                 2,009,095 2,676,980  
Sale of stock description The Company engaged the Placement Agent to act as its exclusive placement agent in connection with the transactions summarized above and agreed to pay the Placement Agent a cash fee equal to 7.0% of the gross proceeds as well as a management fee equal to 1.0% of the aggregate gross proceeds from the exercise of the Existing Warrants, plus reimbursement for certain expenses and the issuance of 14,146 placement agent warrants.                    
Aggregate offering price value           $ 4,244,467          
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs                 1,636,799  
Stock based compensation expenses         $ 186,567   $ 369,200   585,847 1,096,570  
Share-Based Payment Arrangement, Option [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock based compensation expenses         414   414   1,242 5,854  
Unamortized stock-based compensation costs         690       $ 690    
Weighted average period                 4 months 24 days    
Restricted Stock Units (RSUs) [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Stock based compensation expenses         186,567   $ 369,200   $ 585,847 $ 1,096,570  
Unamortized stock-based compensation costs         $ 604,895       $ 604,895    
Weighted average period                 2 years 10 months 13 days    
Restricted stock units vested | shares                 836    
2020 Long Term Incentive Plan [Member] | Board [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Authorized shares reserved | shares                     24,978
Shares available for grant | shares         7,549       7,549    
ATM Agreement [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares | shares                 110,242    
Aggregate offering price value   $ 1,854,151                  
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs                 $ 1,636,799    
Measurement Input, Share Price [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input | Segment       21.72              
Measurement Input, Exercise Price [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input       45.00              
Measurement Input, Expected Term [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Expected life in years       5 years              
Measurement Input, Option Volatility [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input       106              
Measurement Input, Risk Free Interest Rate [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input       4.4              
Measurement Input, Expected Dividend Rate [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input       0              
Pre-Funded Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares | shares       36,444              
Warrants to purchase of shares | shares       36,444              
Exercise price | $ / shares       $ 0.0012              
Stock have been issued due to exercises | shares                 36,444    
Series A Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares | shares       138,889              
Warrants to purchase of shares | shares       138,889              
Series A Warrants [Member] | Measurement Input, Expected Term [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Expected life in years 4 years 4 months 17 days                    
Series A Warrants [Member] | Measurement Input, Option Volatility [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input 129.0                    
Series B Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares | shares       138,889              
Warrants to purchase of shares | shares       138,889              
Stock have been issued due to exercises | shares                 2,084    
Series B Warrants [Member] | Measurement Input, Expected Term [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Expected life in years 10 months 17 days                    
Series B Warrants [Member] | Measurement Input, Option Volatility [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input 134.0                    
Series B Warrants [Member] | Measurement Input, Expected Dividend Payment [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input 0                    
Pre-Funded Warrants and Accompanying Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercise price | $ / shares       $ 35.9988              
Placement Agent Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants to purchase of shares | shares       9,723              
Exercise price | $ / shares $ 13.7256     $ 45.00              
Shares and pre-funded warrant percentage       7.00%              
Public offering price percentage       125.00%              
Warrant expire date       Feb. 03, 2030              
Ffair value of Warrant $ 90,000   $ 147,564                
Series A Warrants and Series B Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercise price | $ / shares $ 36.00                    
Ffair value of Warrant $ 636,662                    
Purchase of warrants | shares 202,083                    
Exercise price of warrants | $ / shares $ 10.98                    
Stock have been issued due to exercises | shares 1,513,449                    
Series A Warrants and Series B Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input 3.6                    
Series C Warrants and Series D Warrants [Member] | Maximum [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Purchase of warrants | shares 404,166                    
Series C Warrants and Series D Warrants [Member] | Measurement Input, Expected Dividend Rate [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input 0                    
Series C Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercise price | $ / shares $ 10.98                    
Expected life in years 5 years                    
Series C Warrants [Member] | Measurement Input, Expected Term [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Expected life in years 5 years 2 months 23 days                    
Series C Warrants [Member] | Measurement Input, Option Volatility [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input 126.0                    
Series C Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input 3.6                    
Series D Warrants [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Expected life in years 18 months                    
Gross proceeds $ 2,218,873                    
Series D Warrants [Member] | Measurement Input, Expected Term [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Expected life in years 1 year 8 months 23 days                    
Series D Warrants [Member] | Measurement Input, Option Volatility [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input 125.0                    
Series D Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding, measurement input 3.5                    
Common Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares | shares       102,444   102,444          
Stock have been issued due to exercises | shares         202,083 38,528   10,856      
Aggregate offering price value           $ 1,024          
Warrant [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Exercise price | $ / shares       $ 36.00